Lindsay Puckett, MD

Publications

• A Survey Study of Female Radiation Oncology Residents' Experiences to Inform Change.

  (Osborn VW, Doke K, Griffith KA, Jones R, Lee A, Maquilan G, Masters AH, Albert AA, Dover LL, Puckett LL, Hentz C, Kahn JM, Colbert LE, Barry PN, Jagsi R.) Int J Radiat Oncol Biol Phys. 2019 Aug 01;104(5):999-1008.

• #WomenWhoCurie: Leveraging Social Media to Promote Women in Radiation Oncology.

  (Albert AA, Knoll MA, Doke K, Masters A, Lee A, Dover L, Hentz C, Puckett L, Goodman CR, Osborn VW, Barry P, Jagsi R.) Adv Radiat Oncol. 2019 Apr-Jun;4(2):218-225.

• Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment.

  (Puckett LL, Luitweiler E, Potters L, Teckie S.) J Oncol Pract. 2017 09;13(9):e782-e791.

• Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.

  (Levy Barazany H, Barazany D, Puckett L, Blanga-Kanfi S, Borenstein-Auerbach N, Yang K, Peron JP, Weiner HL, Frenkel D.) Exp Neurol. 2014 May;255:63-70.

• Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.

  (Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB.) Am J Clin Oncol. 2014 Feb;37(1):57-62.

• Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression.

  (Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L, Farfara D, Kingery ND, Weiner HL, El Khoury J.) Nat Commun. 2013;4:2030.

• Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry.

  (Tejwani A, Bieniek E, Puckett L, Lavaf A, Guirguis A, Bennish A, Ashamalla H.) J Contemp Brachytherapy. 2012 Jun;4(2):75-80.

• Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36.

  (Means TK, Mylonakis E, Tampakakis E, Colvin RA, Seung E, Puckett L, Tai MF, Stewart CR, Pukkila-Worley R, Hickman SE, Moore KJ, Calderwood SB, Hacohen N, Luster AD, El Khoury J.) J Exp Med. 2009 Mar 16;206(3):637-53.

• A nasal proteosome adjuvant activates microglia and prevents amyloid deposition.

  (Frenkel D, Puckett L, Petrovic S, Xia W, Chen G, Vega J, Dembinsky-Vaknin A, Shen J, Plante M, Burt DS, Weiner HL.) Ann Neurol. 2008 May;63(5):591-601.

• Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.

  (Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL.) J Clin Invest. 2008 Apr;118(4):1532-43.